nature.com·1 min read
China now leads the world in trials for next-gen CAR-T therapies
F
Fieldhouse, Rachel
Rachel Fieldhouse is a reporter for Nature in Sydney, Australia.
Search author on: PubMed Google Scholar
Bluesky Facebook LinkedIn Reddit Whatsapp X Save article View saved research CAR-T cell therapies developed in China are quickly moving to trials in patients. via Getty
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in